{"id":28944,"date":"2026-11-16T15:41:35","date_gmt":"2026-11-16T11:41:35","guid":{"rendered":"https:\/\/medscriptum.org\/?p=28944"},"modified":"2026-11-16T15:48:14","modified_gmt":"2026-11-16T11:48:14","slug":"antimicrobial-resistance-threatens-modern-medicine-who-warning","status":"publish","type":"post","link":"https:\/\/medscriptum.org\/en\/antimicrobial-resistance-threatens-modern-medicine-who-warning\/","title":{"rendered":"Antimicrobial Resistance Threatens Modern Medicine \u2014 WHO Warning"},"content":{"rendered":"<p>Senior officials at the World Health Organization (WHO) warn that, despite some progress in tackling drug-resistant bacteria, the spread of antimicrobial resistance (AMR) poses a major threat to modern medicine.<\/p>\n<p>The widespread and irrational use of antibiotics in healthcare, livestock farming and the food industry has accelerated the problem to such an extent that AMR has become one of the leading causes of death from infectious diseases worldwide. According to WHO data, in 2021 alone, antimicrobial resistance directly caused more than 1 million deaths, while 4.7 million deaths were associated with it. The WHO projects that a further 39 million people will die as a result of AMR by 2050.<\/p>\n<p>\u201cAntimicrobial resistance is widespread and threatens the future of modern medicine. Unlike COVID-19, which was highly visible, drug-resistant infections have been silently killing people for years, while we have failed to fully recognize the scale of this threat,\u201d says Jean-Pierre Nyemazi, the WHO&#8217;s acting lead on antimicrobial resistance.<\/p>\n<p>This year, the WHO conducted a survey across 183 countries, which found that nearly 9 out of 10 countries have a national action plan to combat antimicrobial resistance (compared with just 4 out of 10 in 2017). However, as WHO Technical Officer Pravashe Prakash explains, only 42 countries \u2014 fewer than one in five \u2014 have managed to adequately fund, implement and monitor these plans. According to her, progress must accelerate significantly to meet the 2030 targets.<\/p>\n<p>Access to diagnostics remains one of the major weaknesses. Only 36% of countries have a national reference laboratory capable of testing all bacteria and fungi monitored by the WHO for resistance. This falls significantly short of the 80% target set for 2030. According to 2023 data, one in every six laboratory-confirmed bacterial infections reported to the WHO was already resistant to the antibiotics used to treat it.<\/p>\n<p>\u201cWithout testing, clinicians are forced to treat patients without knowing the exact cause of the infection or which antibiotic will work,\u201d explains Sylvia Bertagnolio, the WHO&#8217;s lead for AMR surveillance.<\/p>\n<p>To improve the situation, the WHO has introduced two new tools to help countries strengthen their diagnostic capacities. The first identifies the tests that should be available at every level of the healthcare system, from primary care centres to referral hospitals. The second brings together 73 laboratory procedures, covering everything from sample collection and pathogen identification to antibiotic susceptibility testing.<\/p>\n<p>The WHO emphasizes that the development of new therapies is failing to keep pace with the growing rate of resistance. Therefore, the rational use of existing antibiotics, infection prevention, timely vaccination, and improved access to clean water and sanitation are critically important.<\/p>\n<p><a href=\"https:\/\/medicalxpress.com\/news\/2026-11-alarm-antimicrobial-resistance-threat.html#google_vignette\" target=\"_blank\" rel=\"noopener\">MedicalXpress<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Senior officials at the World Health Organization (WHO) warn that, despite some progress in tackling drug-resistant bacteria, the spread of antimicrobial resistance (AMR) poses a major threat to modern medicine. The widespread and irrational use of antibiotics in healthcare, livestock farming and the food industry has accelerated the problem to such an extent that AMR [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":28942,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1594],"tags":[2461],"class_list":["post-28944","post","type-post","status-publish","format-standard","has-post-thumbnail","category-news","tag-antimicrobial-resistance"],"acf":[],"_links":{"self":[{"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/posts\/28944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/comments?post=28944"}],"version-history":[{"count":1,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/posts\/28944\/revisions"}],"predecessor-version":[{"id":28950,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/posts\/28944\/revisions\/28950"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/media\/28942"}],"wp:attachment":[{"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/media?parent=28944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/categories?post=28944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/tags?post=28944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}